Safety and efficacy of pregabalin in adolescents with fibromyalgia: a randomized, double-blind, placebo-controlled trial and a 6-month open-label extension study

BACKGROUND: Fibromyalgia (FM) is a common pain condition characterized by widespread musculoskeletal pain and tenderness. Pregabalin is an approved treatment for adults in the United States, but there are no approved treatments for adolescents with FM. METHODS: This was a 15-week, randomized, double...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Pediatr Rheumatol Online J
Päätekijät: Arnold, Lesley M., Schikler, Kenneth N., Bateman, Lucinda, Khan, Tahira, Pauer, Lynne, Bhadra-Brown, Pritha, Clair, Andrew, Chew, Marci L., Scavone, Joseph
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: BioMed Central 2016
Aiheet:
Research Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4967327/
https://ncbi.nlm.nih.gov/pubmed/27475753
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12969-016-0106-4
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia